TABLE 3.
Number of events/total number or Total number |
||||||
---|---|---|---|---|---|---|
Outcome | No of trials |
Misoprostol plus oxytocin |
Oxytocin | Relative risk or Mean difference (95% CI) |
P value |
I2 (%) |
Primary outcomes | ||||||
Mean intraoperative blood loss (ml) | ||||||
Sublingual misoprostol | 446,48,50,53 | 454 | 456 | −139 (−300 to 21) | 0.09 | 99 |
Oral misoprostol | 143 | 28 | 25 | −29 (−159 to 101) | 0.66 | NA |
Buccal misoprostol | 141 | 173 | 179 | 24 (−16 to 64) | 0.24 | NA |
Rectal misoprostol | 152 | 200 | 200 | −191 (−252 to −130) | <0.00001 | NA |
Mean postoperative blood loss (ml) | ||||||
Sublingual misoprostol | 153 | 179 | 187 | −265 (−282 to −248) | <0.00001 | NA |
Oral misoprostol | 143 | 28 | 25 | 28 (−30 to 86) | 0.34 | NA |
Rectal misoprostol | 152 | 200 | 200 | −139 (−166 to −112) | <0.00001 | NA |
Mean fall in hemoglobin (g/dl) | ||||||
Sublingual misoprostol | 346,48,50 | 275 | 269 | −0.2 (−0.5 to 0.1) | 0.13 | 66 |
Intrauterine misoprostol | 144 | 100 | 100 | −0.6 (−0.9 to −0.3) | 0.0002 | NA |
Mean fall in hematocrit (%) | ||||||
Sublingual misoprostol | 346,48,53 | 364 | 372 | −2.1 (−3.4 to −0.8) | 0.0001 | 91 |
Buccal misoprostol | 141 | 173 | 179 | −0.2 (−0.5 to 0.1) | 0.11 | NA |
Rectal misoprostol | 152 | 200 | 200 | −3.5 (−4.2 to −2.9) | <0.00001 | NA |
Intrauterine misoprostol | 144 | 100 | 100 | −1.8 (−2.8 to −0.7) | 0.001 | NA |
Use of additional uterotonic agents | ||||||
Sublingual misoprostol | 348,50,53 | 35/329 | 102/331 | 0.33 (0.18 to 0.62) | 0.0005 | 61 |
Oral misoprostol | 143 | 0/28 | 0/25 | Not estimable | NA | NA |
Buccal misoprostol | 141 | 45/173 | 76/179 | 0.61 (0.45 to 0.83) | 0.002 | NA |
Rectal misoprostol | 152 | 14/200 | 36/200 | 0.39 (0.22 to 0.70) | 0.002 | NA |
Intrauterine misoprostol | 144 | 3/100 | 6/100 | 0.50 (0.13 to 1.94) | 0.32 | NA |
Secondary outcomes | ||||||
Blood loss >500 ml | ||||||
Sublingual misoprostol | 150 | 73/90 | 77/84 | 0.88 (0.79 to 1.00) | 0.05 | NA |
Blood loss >1000 ml | ||||||
Sublingual misoprostol | 346,48,50 | 25/275 | 29/269 | 0.85 (0.52 to 1.39) | 0.53 | 0 |
Buccal misoprostol | 141 | 24/173 | 22/179 | 1.13(0.66 to 1.94) | 0.66 | NA |
Blood transfusion | ||||||
Sublingual misoprostol | 346,50,53 | 3/394 | 17/396 | 0.24 (0.02 to 2.60) | 0.24 | 65 |
Oral misoprostol | 143 | 0/28 | 0/25 | Not estimable | NA | NA |
Buccal misoprostol | 141 | 3/173 | 3/179 | 1.03 (0.21 to 5.06) | 0.97 | NA |
Rectal misoprostol | 152 | 0/200 | 0/200 | Not estimable | NA | NA |
Intrauterine misoprostol | 144 | 0/100 | 0/100 | Not estimable | NA | NA |
Postoperative hemoglobin (g/dl) | ||||||
Sublingual misoprostol | 248,50 | 150 | 144 | 0.1 (−0.4 to 0.6) | 0.68 | 64 |
Oral misoprostol | 143 | 28 | 25 | −0.5 (−1.3 to 0.3) | 0.20 | NA |
Intrauterine misoprostol | 144 | 100 | 100 | 0.6 (0.3 to 0.9) | 0.0007 | NA |
Postoperative hematocrit (%) | ||||||
Sublingual misoprostol | 248,53 | 239 | 247 | 1.4 (−2.2 to 5.0) | 0.44 | 95 |
Intrauterine misoprostol | 144 | 100 | 100 | 1.6 (0.6 to 2.6) | 0.002 | NA |
Shivering | ||||||
Sublingual misoprostol | 446,48,50,53 | 87/454 | 43/456 | 2.01 (1.50 to 2.70) | <0.00001 | 34 |
Oral misoprostol | 143 | 10/28 | 2/25 | 4.46 (1.08 to 18.45) | 0.04 | NA |
Pyrexia | ||||||
Sublingual misoprostol | 446,48,50,53 | 44/454 | 17/456 | 2.58 (1.50 to 4.45) | 0.0006 | 8 |
Rectal misoprostol | 152 | 11/200 | 13/200 | 0.85 (0.39 to 1.84) | 0.67 | NA |
Intrauterine misoprostol | 144 | 8/100 | 4/100 | 2.00 (0.62 to 6.43) | 0.24 | NA |
Nausea | ||||||
Sublingual misoprostol | 346,50,53 | 52/394 | 26/396 | 1.90 (0.87 to 4.17) | 0.11 | 64 |
Oral misoprostol | 143 | 0/28 | 1/25 | 0.30 (0.01 to 7.02) | 0.45 | NA |
Vomiting | ||||||
Sublingual misoprostol | 246,50 | 20/215 | 13/209 | 1.51 (0.78 to 2.95) | 0.22 | 0 |
Intrauterine misoprostol | 144 | 3/100 | 3/100 | 1.00 (0.21 to 4.84) | 1.00 | NA |
Diarrhea | ||||||
Sublingual misoprostol | 153 | 2/179 | 0/187 | 5.22 (0.25 to 108.0) | 0.28 | NA |
Intrauterine misoprostol | 144 | 0/100 | 0/100 | Not estimable | NA | NA |
Abdominal pain | ||||||
Sublingual misoprostol | 153 | 24/179 | 13/187 | 1.93 (1.01 to 3.67) | 0.04 | NA |
Intrauterine misoprostol | 144 | 7/100 | 8/100 | 0.88 (0.33 to 2.32) | 0.79 | NA |
Headache | ||||||
Sublingual misoprostol | 146 | 4/125 | 2/125 | 2.00 (0.37 to 10.72) | 0.42 | NA |
Oral misoprostol | 143 | 0/28 | 1/25 | 0.30 (0.01 to 7.02) | 0.45 | NA |
Any side effect | ||||||
Sublingual misoprostol | 146 | 48/125 | 19/125 | 2.53 (1.58 to 4.04) | 0.0001 | NA |
Apgar score at 1 min | ||||||
Rectal misoprostol | 152 | 200 | 200 | −0.3 (−0.6 to 0.0) | 0.08 | NA |
Apgar score at 5 min | ||||||
Rectal misoprostol | 152 | 200 | 200 | 0.2 (0.1-0.3) | 0.005 | NA |
NICU admission | ||||||
Rectal misoprostol | 152 | 6/200 | 9/200 | 0.66 (0.23-1.88) | 0.43 | NA |
CI, confidence interval; NA, not applicable; NICU, neonatal intensive care unit